Today we produce almost 100% of Servier medicines intended for Polish patients.
These are preparations/medicines used in cardiology, including part of combined preparations/medicines in the treatment of depression, diabetes, and one product used in inflammatory airways.
Export accounts for almost 50% of drugs produced by us. The largest export market is the French market at 25% of annual volume. There are currently 31 products produced at the request for the French market.